China’s Rise in Drug Development Looms Over U.S. - The New York Times

China’s Rise in Drug Development Looms Over U.S. The New York Times Growing US reliance on Chinese biotechs prompts national security fears Financial Times China’s biotech ascent forces US industry to choose: Is the country an ally or an existential threat? The Boston Globe As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing? Fierce Biotech This Emerging Risk Is Unlike Anything the Biotech Industry Has Ever Experienced The Motley Fool